Acclinate increases clinical trial diversity through NOWINCLUDED, the community engagement arm of Acclinate and uses predictive analytics to provide valuable insights to pharmaceutical companies and other healthcare organizations. Acclinate provides access to communities of color, facilitates engagement around trials, and then analyzes the data generated to predict and plan where and when clinical research should happen.
Primary Goals for Redesign:
